Update on March 13th, 2023 – Source
- Amazon has banned the sales of NMN on their platform. All products are off of the site now.
Update on March 7th, 2023 – Source
- Two health organization requested that the FDA reverse its position that NMN, is excluded from the definition of a dietary supplement.
- Alliance for Natural Health USA (ANH) and Natural Products Association (NPA) asked that the FDA make the determination above or “commit to exercise enforcement discretion in connection with the marketing and selling of NMN in or as a dietary supplement.”
- They submitted this request through in a 12-page citizen petition.
Update on February 16th, 2023 – Source
- Amazon has announced that it will be banning the sale of NMN (nicotinamide mononucleotide) starting Monday, March 13 2023.
Update on January 23rd, 2023 – Source
- The Natural Products Association (NPA) requested to open a docket on β-NMN (beta-nicotinamide mononucleotide)
- The FDA denied the request, with the conclusion that interested parties already had the chance to submit relevant information to them
- On January 20th, Cara Welch, who oversees FDA’s Office of Dietary Supplement Programs (ODSP), wrote a letter to Dan Fabricant, NPA CEO.
- To read the full letter from the FDA to NPA CEO Dan Fabricant, click here to download it.
Update on December 16th, 2022 – Source
- Dr. David Sinclair has finally released a statement on the situation
- Click here to read it
Update on December 7th, 2022 – Source
- Manufacturers have been advised to stop the production of NMN dietary supplements
- This may lead to shortages in the near future
- Retailers have not been told to stop selling it, yet
Update on December 4th, 2022 – Source
- Natural Products Association (NPA) Met with the FDA November 30th, 2022
- After that meeting, NPA CEO Dan Fabricant requested the FDA to open a docket on NMN
- The docket would allow stakeholders the ability to submit information and comments to the agency regarding the NMN’s presence in food and supplements
- The NPA shared documents with the FDA related to the possibility of NMN being marketed as a food or dietary supplement prior to it being investigated as a new drug
- The documents include a few patents related to NMN in food and supplements, plus an announcement by a company over four years ago that said its ingredient was self-affirmed GRAS (generally recognized as safe)
- For more details on the meeting, checkout the post here on Natural Products Insider